white house declined pfizer's offer to secure more covid-19 vaccine doses: board member gottlieb
Published 3 years ago • 66K plays • Length 3:56Download video MP4
Download video MP3
Similar videos
-
3:48
jim cramer on the white house declining pfizer's offer for additional covid-19 vaccine doses
-
2:04
u.s. turned down more covid-19 vaccines as recently as november 2020: gottlieb
-
2:49
pfizer board member scott gottlieb on variant-specific covid vaccine
-
2:31
pfizer board member dr. scott gottlieb on company's vaccine timeline
-
2:55
pfizer board member scott gottlieb: states will manage distribution of coronavirus vaccine
-
6:53
new pce data shows economy can continue expanding while inflation moves down, says lael brainard
-
7:05
upside for emergent bio if they can get mpox vaccine rollout right, says mizuho's jared holz
-
3:00
consumer spending is driving inflation: economist
-
2:23
dr. scott gottlieb on debate over covid-19's origin
-
2:59
pfizer board member scott gottlieb: '2021 will look very different from 2020'
-
3:19
pfizer board member dr. scott gottlieb on fda's move toward emergency approval
-
2:40
pfizer board member scott gottlieb on promising preliminary vaccine results
-
3:04
pfizer board member dr. scott gottlieb details likelihood of coronavirus vaccine in late november
-
2:36
former fda chief on white house transition of coronavirus task force
-
4:53
fmr. fda chief scott gottlieb on global vaccine distribution
-
4:29
i’m hopeful we'll have enough covid-19 supply in 2021: dr. gottlieb on pfizer vaccine rollout
-
6:54
dr. scott gottlieb on j&j vaccine trial results, covid mutations and more
-
2:07
dr. scott gottlieb sees covid-19 vaccine in 'rationing type of environment' well into the spring
-
5:06
dr. scott gottlieb on omicron variant: we have the tools to deal with this
-
3:43
former fda chief scott gottlieb on challenges of distributing the covid-19 vaccine in the u.s.
-
5:14
dr. scott gottlieb on the approval and rollout of booster shots
-
1:35
millions of coronavirus vaccine doses could be ready in the fall for human trials: dr. gottlieb